BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25339476)

  • 1. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
    Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
    Radestock Y; Hoang-Vu C; Hombach-Klonisch S
    Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
    Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
    APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
    Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
    Ma J; Huang H; Han Z; Zhu C; Yue B
    Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
    Ling Z; Li R
    Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
    Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
    Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
    Zhu H; Tang J; Tang M; Cai H
    Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.